STOCKWATCH
ยท
Pharmaceuticals
Sale30 Jun 2025, 06:25 pm

Bafna Pharmaceuticals Ltd Completes Sale of Manufacturing Unit to Navron Pharma Private Limited

AI Summary

Bafna Pharmaceuticals Ltd has executed an agreement for the Sale / Disposal of its manufacturing unit located at No. 13, S.V. Koil Street, Madhavaram, Chennai โ€” 600060 to M/s. Navron Pharma Private Limited. The transaction was completed on June 30, 2025. The Madhavaram Unit contributed 0.08% to the revenue and 1.55% to the net worth of the company as on March 31, 2025. The agreement was entered into on June 23, 2025, and the sale/disposal is expected to be completed on the same date. The consideration received from the sale/disposal is Rs.1,45,13,260/-.

Key Highlights

  • Bafna Pharmaceuticals Ltd completes the sale of its manufacturing unit to Navron Pharma Private Limited.
  • The transaction was completed on June 30, 2025.
  • The Madhavaram Unit contributed 0.08% to the revenue and 1.55% to the net worth of the company as on March 31, 2025.
  • The agreement was entered into on June 23, 2025.
  • The consideration received from the sale/disposal is Rs.1,45,13,260/-.
BAFNAPHARM
Pharmaceuticals
BAFNA PHARMACEUTICALS LTD.

Price Impact